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The extracellular ligand-induced extrinsic pathway of
apoptosis is executed via caspase protease cascades
that activate downstream effectors by means of site-di-
rected proteolysis. Here we identify proteome changes
upon the induction of apoptosis by the cytokine tumor
necrosis factor–related apoptosis-inducing ligand (TRAIL)
in a Jurkat T cell line. We detected caspase-dependent
cleavage substrates by quantifying protein intensities be-
fore and after TRAIL induction in SDS gel slices. Apoptotic
protein cleavage events are identified by a characteristic
stable isotope labeling with amino acids in cell culture
(SILAC) ratio pattern across gel slices that results from
differential migration of the cleaved and uncleaved pro-
teins. We applied a statistical test to define apoptotic
substrates in the proteome. Our approach identified more
than 650 of these cleaved proteins in response to TRAIL-
induced apoptosis, including many previously unknown
substrates and cleavage sites. Inhibitor treatment com-
bined with triple SILAC demonstrated that the detected
cleavage events were caspase dependent. Proteins lo-
cated in the lumina of organelles such as mitochondria
and endoplasmic reticulum were significantly underrepre-
sented in the substrate population. Interestingly, caspase
cleavage is generally observed in not only one but several
members of stable complexes, but often with lower stoichi-
ometry. For instance, all five proteins of the condensin I
complex were cleaved upon TRAIL treatment. The apopto-
tic substrate proteome data can be accessed and visual-
ized in the MaxQB database and might prove useful for
basic and clinical research into TRAIL-induced apoptosis.
The technology described here is extensible to awide range
of other proteolytic cleavage events. Molecular & Cellular
Proteomics 12: 10.1074/mcp.M112.024679, 1436–1450,
2013.
Apoptosis is an essential cellular mechanism regulating
normal physiological processes, for instance, in development
(1, 2). As a specific and programmed form of cell death,
apoptosis leads to a controlled disposal of cells, relying on the
proteolytic cleavage of specific protein substrates as the cen-
tral mechanism. Moreover, the selective induction of apopto-
sis plays an important role in diseases such as cancer. It is
thus important to determine the proteins and pathways in-
volved in apoptosis and to characterize their relevance for
induction of the pathway by different stimuli. The main players
in apoptosis are caspases (Cys-dependent Asp-specific pro-
teases), which specifically cleave C-terminally of an aspartate
and are represented by 11 functional genes in the human
genome. Auto-cleavage of upstream caspases in response to
the induction of apoptosis initiates a cascade of downstream
cleavage events resulting in activation or inactivation, as well
as translocation, of these substrates (3–6).
In recent years, several methods have been introduced to
identify substrates cleaved in a caspase-dependent manner,
as well as the exact location of cleavage sites. In vitro ap-
proaches such as the incubation of peptides or protein librar-
ies with the active protease of interest have led to the identi-
fication of substrate motifs but do not necessarily represent in
vivo events in the context of an intact cell (7). Mass spectrom-
etry (MS)-based methods employed may be divided into
those directed toward the detection of the peptides cleaved
by the protease and those applied at the proteome level for
the identification of substrates and downstream effects. The
former methods generally chemically block all preexisting N-
termini and subsequently take advantage of the de novo
generation of N-termini by the protease, which serves as a
handle to enrich and detect the corresponding peptide. The
original method in this class was N-terminal COFRADIC (8, 9),
and it was used to detect Fas-induced cleavage events in
Jurkat T cells (10). Recent peptide-selective methods include
the exclusive labeling of novel N-termini by biotin followed by
peptide capture on avidin columns (11), but others, using both
positive and negative selection strategies, have also been
described (12–15). Peptide-based methods have the advan-
tage of allowing direct identification of the cleavage site.
Information about the substrate protein, however, is limited to
a single peptide per cleavage event, and this peptide might
not be readily detectable.
Global approaches applied at the proteome level, in con-
trast, attempt to identify as many cleaved proteins as possible
From the ‡Department of Proteomics and Signal Transduction,
Max-Planck Institute of Biochemistry, Am Klopferspitz 18, D-82152
Martinsried, Germany; §Evotec (Munich) GmbH, Am Klopferspitz 19a,
D-82152 Martinsried, Germany; ¶Weill Cornell Medical College in
Qatar, Qatar Foundation, Education City, Doha, State of Qatar
Author’s Choice—Final version full access.
Received October 3, 2012, and in revised form, December 19, 2012
Published, MCP Papers in Press, January 13, 2013, DOI 10.1074/
mcp.M112.024679
Technical Innovative and Resources
Author’s Choice © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
This paper is available on line at http://www.mcponline.org
1436 Molecular & Cellular Proteomics 12.5
without necessarily determining the exact cleavage site within
the protein (16, 17). In many cases, two-dimensional gel elec-
trophoresis has been used to differentiate cleaved and un-
cleaved protein states (18–20). This approach, however, lacks
reproducibility, sensitivity, and throughput. A pioneering study
based on one-dimensional SDS page identified several pre-
viously known cleaved proteins in Fas-induced Jurkat T cells
by their molecular mass shift, yet it remained small in scale
(21). The approach was further extended to include the quan-
titative ratio information of the proteins in combination with
offline LC-MALDI-MS/MS (22).
Building on these studies, Cravatt and coworkers extended
a global approach that takes into account information about
molecular weight differences between uncleaved and corre-
sponding cleaved proteins, termed PROTOMAP (23). Identi-
fied peptides were mapped onto the protein sequences to
provide information about the location of the cleavage prod-
ucts. Because label-free quantitation is used and samples
consequently are processed in parallel, the approach is labor
intensive and requires high reproducibility of the experiments.
In an attempt to circumvent the limitations of the methods
mentioned above, we set out to develop a quantitative
method based on stable isotope labeling with amino acids in
cell culture (SILAC)1 for the identification of apoptosis-de-
pendent substrates of protein cleavage on the proteome level,
but making use of accurate peptide-based ratio information
for each substrate protein. In this way, we aimed to combine
advantages of each of the above approaches. Furthermore,
we included in our analysis a combination of a high-resolution
LC-MS/MS workflow with stringent statistical analysis of the
results.
Several previous proteomics studies of apoptosis have in-
vestigated the effects of intrinsic stimuli. Despite its impor-
tance for the development of cancer therapeutics, no global
proteome study has characterized cleavage events induced
by the extrinsic stimulus tumor necrosis factor–related apop-
tosis-inducing ligand (TRAIL), apart from one targeted study
focusing on cleavage kinetics (24). In that study, TRAIL-
treated (extrinsic) and staurosporine-treated (intrinsic) sam-
ples were compared via the selected reaction monitoring of
1,000 caspase-derived peptides. In our study, we per-
formed triple SILAC labeling in the well-established system of
TRAIL-induced apoptosis in Jurkat T cells, which allowed us
to validate the caspase dependence of the detected cleavage
events. Our study sheds light on the fate of protein complexes
in cell death and provides the first in-depth overview of
cleaved substrates in response to extrinsic TRAIL-induced
apoptosis.
During the preparation of this manuscript, a report by the
Cravatt group extended their PROTOMAP approach (23) us-
ing SILAC, making it quantitative (25). That study elegantly
extracts information on the crosstalk between phosphoryla-
tion events in the cleavage motifs and the regulation of the
proteolytic pathway in apoptosis. It thereby underscores the
necessity and potential of quantitative approaches for the
study of proteolytic events in a global manner.
EXPERIMENTAL PROCEDURES
Evaluation of TRAIL Treatment and Inhibitor Concentrations—Jur-
kat T cells (0.4  106 cells/ml) were treated with 50 ng/ml, 100 ng/ml,
200 ng/ml, or 500 ng/ml human TRAIL Apo-II ligand (PeproTech, Inc.,
Rocky Hill, NJ; 50 g, stock 100 ng/l) or mock and incubated at
37 °C in 5% CO2 for 24 h. Cell growth was regularly examined, and
cell morphology was checked using 5-h light microscopy and a cell
counter (Countess, Invitrogen, Life Technologies, Grand Island, NY).
Based on these experiments, a concentration of 100 ng/ml was
selected for further analyses.
Jurkat T cells were treated with varying concentrations of the
pan-caspase inhibitor z-VAD-FMK (0.1 M, 1 M, 10 M, and 50 M in
2 ml (0.75  106 cells/ml); R&D Systems, Minneapolis, MN; 1 mg) 10
min prior to 5 h of incubation with 100 ng/ml of either TRAIL or mock.
Cells were washed twice with ice-cold PBS, and cell pellets were
frozen at 80 °C until further analysis using Western blotting.
Flow Cytometry Analysis—For the detection of apoptotic and ne-
crotic cells, the Annexin V-FITC Kit (Apoptosis Detection Kit, Beck-
man Coulter, Krefeld, Germany) was used. Cells were washed and
resuspend in ice-cold water. An antibody mix for propidium iodide/
Annexin V-FITC (1:20 propidium iodide and 1:100 Annexin-V FITC)
was prepared and added to the cells in Binding Buffer. Cells were
kept on ice until flow cytometric analysis. Cells were analyzed after 0,
1, 2, 4, and 5 h of TRAIL induction.
SILAC Labeling—Jurkat T cells were cultured in RPMI medium
(high-glucose GlutaMAXTM devoid of arginine and lysine; Invitrogen)
supplemented with 10% dialyzed fetal bovine serum (FBS) (Invitro-
gen) (10 kDa cut-off) and 1X penicillin/streptomycin. For SILAC label-
ing, arginine and lysine were added in either light (Arg0; Lys0) or
heavy (Arg10; Lys8) forms to a final concentration of 33.6 g/ml for
arginine and 73 g/ml for lysine. For triple labeling, cells were addi-
tionally cultured in medium containing Arg6 and LysD4 using the
same concentrations. L-arginine (Arg0), L-lysine (Lys0), L-13C6-argi-




15N2-lysine (Lys8) were purchased from Sigma-Aldrich. Prior to
treatment, Jurkat T cells were grown for 8 to 10 passages in SILAC
medium and tested for full incorporation.
Treatment with TRAIL—Equal numbers of Jurkat T cells (0.4 to
0.6  106 cells/ml) were treated for 5 h with 100 ng/ml TRAIL or mock
in heavy and light medium. For the inhibition study, medium labeled
cells were additionally pre-treated for 10 min with 50 M z-VAD-FMK.
TRAIL treatment was stopped by the addition of ice-cold PBS to the
cells. Cell suspensions were centrifuged (5 min, 4 °C, 400 g), and the
supernatant was discarded. Cell pellets from the corresponding
heavy and light cultures (or heavy, medium, and light for triple-
labeling experiments) were resuspended in a small aliquot of ice-cold
PBS and combined in one tube. Cells were once more washed with
ice-cold PBS and centrifuged. Cell pellets were shock-frozen in liquid
nitrogen and stored at 80 °C.
Cell Lysis and Protein Digestion—Proteins were extracted and
digested following the first steps of the filter-aided sample prepara-
tion protocol (26). Cells were lysed with 4% SDS and 0.1 M DTT in 100
mM Tris/HCl pH 7.6, followed by incubation for 5 min at 95 °C.
Lysates were sonicated and cleared via centrifugation at high speed
1 The abbreviations used are: CASP8, Caspase-8; FDR, false dis-
covery rate; FMK, fluoromethylketone; SILAC, stable isotope labeling
with amino acids in cell culture; TRAIL, tumor necrosis factor–related
apoptosis-inducing ligand.
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(16,000  g). Protein concentrations were measured using a trypto-
phan-fluorescence assay. 150 g of the samples were used for
further analyses. Proteins were reduced with DTT (10 mM) for 45 min
at room temperature, and reduction was followed by alkylation for 30
min in the dark (55 mM iodoacetamide).
Proteins were mixed with LDS sample buffer (final: 1x; Invitrogen)
and samples were boiled at 70 °C for 10 min. 50 g of protein per
sample were loaded on a polyacrylamide gel (Bis-Tris Gel, Invitrogen,
4%–12%, MOPS; 10 pockets) in each of three adjacent lanes (total of
150 g per sample). Proteins were separated with 180 V for 45 min.
Proteins were fixed and stained in the gel using standard protocols
(Colloidal Blue Staining Kit, Invitrogen).
The gel was cut into between 28 and 36 slices, and corresponding
slices from the three lanes were combined in one tube. Proteins in the
gel were digested via standard in-gel protocols (27). Briefly, gel
pieces were destained in consecutive wash steps and dehydrated
using 50% and 100% ethanol. Gel pieces were dried in a SpeedVac
concentrator for 5 min. Proteins were digested via the addition of
sequencing-grade modified trypsin (12.9 ng/ml; Promega, Madison,
WI) to the gel pieces followed by an overnight incubation at 37 °C.
Peptides were subsequently extracted from the gel pieces using
increasing concentrations of acetonitrile (30% to 100% acetonitrile) in
separate steps. Organic solvent was removed in a SpeedVac con-
centrator, and peptides were desalted on reversed-phase C18
StageTips (Empore disk (28)) prior to LC-MS/MS analysis.
Western Blot Experiments—Cell pellets were lysed and proteins
were separated via SDS-PAGE as mentioned before. As positive and
negative controls, 10- to 15-l Jurkat apoptosis cell lysates (etopo-
side-treated and untreated; Cell Signaling, Danvers, MA) were used.
For CASP8 detection, 12% NuPAGE Bis-Tris Gels (Invitrogen) were
used. For PARP1 analysis, 4%–12% Bis-Tris gels were used. All gels
were run with MOPS buffer. Proteins were transferred onto a nitro-
cellulose membrane using a vertical blotting system for 1 h at 100 V.
Primary antibodies in 1% BSA or nonfat dry milk were added to the
membrane for 1 h at room temperature or were left overnight at 4 °C.
The second antibody (in Tween 20 Tris-buffered saline buffer) was
added for 30 min to 1 h at room temperature. Antibodies were used
as follows: PARP (46D11) rabbit mAb (Invitrogen), 1:1,000 in milk;
caspase-8 (1C12) mouse mAb (Invitrogen), 1:1,000 in BSA; GAPDH
rabbit, 1:1,000 in milk or 5% BSA (Invitrogen), 1:3,000 2nd Ab rabbit
(GE Healthcare); 1:10,000 2nd Ab mouse (Jackson ImmunoResearch
Laboratories, Newmarket, UK).
LC/MS—Peptide mixtures were analyzed using nanoflow liquid
chromatography (LC-MS/MS) on an EASY-nLC system (Proxeon Bio-
systems, Odense, Denmark (now Thermo Fisher Scientific)) on-line
coupled to an LTQ Orbitrap XL or LTQ Orbitrap Velos instrument
(Thermo Fisher Scientific, Bremen, Germany (29, 30)) through a na-
noelectrospray ion source (Proxeon). Approximately 4 g of the pep-
tide samples in 5 l were directly loaded onto a 15-cm column with
75-l inner diameter, packed in-house with 3-m reversed-phase
beads (ReproSil-Pur C18-AQ, Dr. Maisch, Ammerbuch-Entringen,
Germany, GmbH). Peptides were separated and directly electros-
prayed into the mass spectrometer using a 145 min method including
a linear gradient from 5% to 30% acetonitrile in 0.5% acetic acid over
93 to 97 min at a constant flow of 250 nl/min.
The LTQ Orbitrap XL and LTQ Orbitrap Velos were operated in
data-dependent mode, switching automatically between full-scan MS
and MS/MS acquisition. Instrument control was through Tune 2.6.0.
and Xcalibur 2.1.0. Full-scan MS spectra (m/z 300–1,650) were ac-
quired in the Orbitrap analyzer after accumulation to a target value of
106 in the linear ion trap. Spectra were acquired with a resolution of
60,000 at 400 m/z. The 5 (LTQ Orbitrap XL) and 15 (LTQ Orbitrap
Velos) most intense ions with charge states  2 were sequentially
isolated with a target value of 5,000 and fragmented using collision-
induced dissociation in the linear ion trap with a normalized collision
energy of 35%. The activation q was set at 0.25, and the activation
time was set at 30 ms and 10 ms for the LTQ Orbitrap and LTQ
Orbitrap Velos, respectively. The ion selection threshold was set at
500 counts for collision-induced dissociation MS/MS. Maximum ion
accumulation times of 1,000 ms and 500 ms for full scans and 150 ms
and 25 ms for collision-induced dissociation MS/MS scans were set
for the LTQ Orbitrap XL and the LTQ Orbitrap Velos, respectively. The
dynamic exclusion was 90 s with early expiration enabled (count: 2;
S/N threshold: 2). Standard MS parameters were set for all experi-
ments as follows: 2.2 kV spray voltage; no sheath and auxiliary gas;
200 °C heated capillary temperature; predicted and normal automatic
gain control enabled for Velos analyses (for Orbitrap data, normal
automatic gain control was enabled); 110 V tube lens voltage (LTQ
Orbitrap) and 50% to 60% S-lens radio frequency level (LTQ Orbitrap
Velos); if used, a lock mass of m/z 445.120024 was applied (29); for
LTQ Orbitrap Velos measurements, the lock mass abundance was set
at 0%.
Sample Processing—For the experiments DOUBLE E1 R0K0,
DOUBLE E2 R0K0, and DOUBLE E2 R10K8, Jurkat T cells
were labeled in both heavy and light SILAC medium. Amino acids
marked in the experiment title indicate the labeling of the TRAIL-
induced cells. Reverse labeling was performed as well. For triple-
labeling experiments (TRIPLE Inh TRAIL M1–3), light cultures
were treated with mock, heavy cultures were treated with TRAIL, and
medium cultures were treated with both z-VAD-FMK inhibitor and
TRAIL.
Data Analysis—Raw files of each double- and triple-labeling Jurkat
T cell experiment were analyzed together using the in-house-built
software MaxQuant (version 1.1.1.35 (31, 32)). Each raw file from a
particular slice was defined as a separate experiment in the experi-
mental design file to obtain peptide ratios for each peptide in each
slice. The derived peak list was searched with Andromeda (33)
against the human International Protein Index protein sequence da-
tabase (ipi.HUMAN.v3.68.fasta; 87,083 entries) supplemented with
262 frequently observed contaminants such as human keratins, bo-
vine serum proteins, and proteases and concatenated with the re-
versed copies of all sequences. We required strict enzyme specificity
with cleavage C-terminal after K, R, or D (trypsin  Asp-C), allowing
up to two missed cleavage sites. Fixed modifications of cysteine
carbamidomethylation (Cys 57.021464 Da) and variable modifications
for the N-acetylation of proteins (N-term 42.010565 Da) and the
oxidation of methionine (Met 15.994915 Da) were specified. Double or
triple labeling was defined accordingly. The minimum peptide length
was set as six amino acids. Scoring was performed in MaxQuant as
described previously (31). Parent masses and fragment ions were
searched with initial mass tolerances of 7 ppm and 0.5 Da, respec-
tively. False discovery rates (FDRs) at the peptide and protein levels
were fixed at 1%, including automatic filtering on peptide length,
mass error precision estimates, and peptide scores of all forward and
reversed peptide identifications. The re-quantification feature was
enabled. Reported protein groups had to be identified by at least one
“razor peptide” (a peptide most likely belonging to the protein group)
in order to be accepted. Quantitation was based on unique and razor
peptides only, and a minimum of two ratio counts was required.
Complete protein and peptide lists, as well as the underlying RAW
files, are available in the Proteome Commons Tranche database.
Statistical Identification of Cleavage Events—The obtained lists of
peptides and proteins were further processed with an in-house-de-
veloped program implemented in MATLAB (MathWorks, Natick, MA).
All ratios were converted into log2 values. Ratios of reverse labeling
experiments were inverted beforehand. A protein was determined to
be an apoptosis substrate if the peptides in the slices representing
molecular weights smaller than that of the full-length protein were
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more abundant in apoptotic cells than in untreated cells. A statistical
non-parametric test was applied to determine the confidence of the
identification of cleaved proteins. In brief, for each identified protein
group, the slice with the most peptides that had SILAC ratios smaller
than 1 between TRAIL treated cells and untreated controls was se-
lected as slice s0 containing the uncleaved protein. The t test statis-
tics were calculated between the ratios of peptides in slice s0 and
ratios of peptides in slices s  s0, for which the average ratio was
larger than 1.5. The statistical test was repeated 1,000 times with
randomly permutated slices to evaluate the FDR. Finally, this value
was corrected for multiple-hypotheses testing via the Benjamini–
Hochberg method (34).
For each protein group, a plot presenting the identified peptides as
boxes in a two-dimensional map was generated. The x-axis of the map
represented the position of the peptide with respect to the protein
sequence. The y-axis represented the slice in which the peptide was
detected. The boxes were color-coded according to the ratio be-
tween TRAIL-treated and untreated cells. If peptides cleaved at the
C-terminus of aspartic acid were identified, the corresponding cleav-
age site was marked by a solid line if the SILAC ratio of the cleaved
peptide was greater than 1.5, and by a dotted line otherwise. Simi-
larly, potential cleavage positions that matched the sequence motif
x[ET]xD and known cleavage positions were marked in the plots as
additional information for the reader. Protein sequences and domains
were obtained from Uniprot web services.
The second y-axis in the plots represented the estimated molecular
weight. The mapping of slices to molecular weights was done via
linear regression. For each protein group, the intensity-weighted av-





, was determined, where k  1, . . ., K
enumerate the slices and Iik is the extracted ion current of protein i in
slice k. The linear function ln(m)  a  bs with the parameters a and
b was then fitted to the data (si, ln(mi)), where mi is the molecular
weight of protein i.
The MaxQuant results, the results of the filtered substrates includ-
ing statistical information, and the list of known cleavage sites were
uploaded to the publicly available database MaxQB (35). Additionally,
the three-dimensional cleavage plots of all identified cleavage sub-
strates have been visualized in MaxQB can be obtained at http://
maxqb.biochem.mpg.de. Instructions on how to use MaxQB for vi-
sualizing and extracting cleavage information are provided as
supplemental information. In addition, all .m files for the MATLAB
script are provided on the MaxQB web page to allow researchers to
analyze their data with regard to proteolytic cleavage events (http://
maxqb.biochem.mpg.de/mxdb/project/show/9213156110000).
Data Representation—Data were depicted using GraphPad Prism
(version 5.04) and the free software environment R.
Enrichment Analyses—Cleavage events are more likely to be de-
tected in highly abundant proteins. In order to remove this effect of
abundance as a confounding variable, we first generated a back-
ground distribution of the whole proteome data with an intensity
distribution identical to that of the cleaved proteins. To this end, the
intensity range was binned and each protein group from the whole
dataset was randomly drawn with a probability equal to the propor-
tion of cleaved proteins in the corresponding bin out of the total
number of cleaved proteins. Fisher’s exact test was then used to
identify gene ontology categories that were significantly enriched or
depleted (Benjamini–Hochberg FDR 0.02) in the cleaved population
relative to the background population.
RESULTS AND DISCUSSION
Development of a SILAC-based Quantitative Approach to
Detect Proteolytic Substrates—When proteolytically cleaved
proteins change their molecular weight relative to their un-
cleaved counterparts, it can be detected in an SDS gel as a
shift of the cleaved protein to a lower-molecular-weight re-
gion. We took advantage of this fact to extract information
about cleaved proteins from complete proteome datasets. For
direct comparison, we combined treated and untreated states
in one quantitative SILAC experiment. As both samples were
merged at the cell level, this eliminated errors arising from a
lack of reproducibility and differences in sample processing.
In our SILAC experiments, untreated cells were labeled with
light RPMI medium (Arg0; Lys0) and cells used for treatment
were labeled with heavy medium (Arg10; Lys8) before the
induction of apoptosis (Fig. 1A). We also included label-swap
experiments as an additional check of the method (supple-
mental Fig. S1A).
We applied the SILAC-based approach to investigate
cleavages induced by treatment with TRAIL. Populations of
SILAC-labeled Jurkat T cells that had been treated with TRAIL
or mock control for 5 h were merged, and their lysates were
separated on one-dimensional SDS gels. To achieve high
molecular weight resolution, we cut the gel into between 28
and 36 horizontal slices and followed this with standard in-gel
digestion and LC-MS/MS analysis on ion trap Orbitrap instru-
ments. Data were analyzed with the MaxQuant software as in
our standard workflows; however, the output data were fur-
ther processed in order to identify cleaved caspase sub-
strates (see “Experimental Procedures”) by means of sophis-
ticated filtering. For this processing step, we developed a
statistical algorithm that specifically extracts proteins with a
distinct peptide distribution pattern as a function of gel slice
position. In-gel digestion of a particular gel slice creates pep-
tides from the embedded proteins that represent a certain
mass range (the apparent molecular weight of that gel posi-
tion). The software provides the localization of all detected
peptides from each protein in two dimensions: within the gel
according to the apparent molecular weight region, and along
the protein sequence according to the location of the identi-
fied peptide (Fig. 1B). Peptides from the uncleaved protein are
expected to be located in higher molecular weight regions
and to cover the protein sequence without bias to sequence
location. In contrast, cleaved apoptotic fragments of the same
protein should migrate to a lower molecular weight region,
and the identifying peptides should span only a certain part of
the protein sequence in accordance with the cleavage posi-
tion. The quantitative information obtained via SILAC labeling
then provides a third dimension. These SILAC peptide ratios
encode information about the extent to which the protein or
fragment comes from the treated or untreated state. Peptides
from the uncleaved protein are mainly derived from the un-
treated cells (negative treated/untreated ratio after log trans-
formation) when they are from a high mass region, whereas
peptides derived from corresponding cleaved fragments are
mainly derived from the apoptotic state (positive treated/un-
treated ratio) if they are from the relatively lower gel position.
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FIG. 1. Representation of the SILAC-based approach for the detection of proteolytic substrates. A, schematic overview of the SILAC
experiment followed by stringent statistical data filtering to extract caspase-dependent cleavage substrates. In a SILAC double-labeling
experiment, the cells are treated with an apoptotic stimulus (heavy condition) or mock (light condition). Cells are combined and lysed, and
proteins are separated via SDS-PAGE. After in-gel digestion, each slice is analyzed via LC-MS/MS. Cleavage candidates are identified on the
basis of specific cleavage criteria and via the application of statistics to the data. Graphs are generated for each candidate and manually
inspected before the generation of a final substrate list. DR, death receptor. B, Three-dimensional cleavage plot representation. The plot
combines both experimental data and background information. Detected peptides are depicted as squares defined by slice and sequence
localization, including the color-coded corresponding ratio. Detected cleavages C-terminal of Asp are highlighted within the plot by red lines.
Supplemental information includes theoretical cleavage of the protein (peptides are plotted as squares), known and hypothetical cleavage sites
along the protein sequence, and known protein domains and motifs. Blue and red arrows indicate the location of the uncleaved and cleaved
regions, respectively. Information provided within the graph is explained below the three-dimensional cleavage plot. Experimental data are
depicted in the main upper part of the plot, and specific information at the bottom of the plot.
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The slice with the highest sequence coverage combined with
a median log ratio around zero corresponds to the uncleaved
protein. Slices at lower molecular weights with median posi-
tive ratios correspond to the cleaved fragments. The third
dimension is represented in our plots as a heat map value (red
for positive SILAC log ratios and blue for negative log SILAC
ratios; Fig. 1B). Importantly, the above-mentioned criteria
should be fulfilled concurrently; that is, the uncleaved protein
and its SILAC and sequence values should be consistent with
the cleaved product or products and their location, SILAC
ratios, and distributions of peptides in the protein sequence.
To statistically formalize these criteria, the software defines
these cleaved and uncleaved regions of a protein and calcu-
lates p values and an FDR for the significance of being a
cleavage product (see “Experimental Procedures”). Only pro-
teins with an FDR value below 5% were considered as sig-
nificant candidates, and only for these were graphs created.
We marked theoretically detectable peptides to give an im-
pression of the highest possible sequence coverage of the
protein. In addition to the experimental data, we also included
data from the literature in the graphs. For instance, known
cleavage sites of proteins in the substrate database that we
created (see below), as well as possible cleavage sites follow-
ing the x[ET]xD caspase cleavage motif, are indicated as red
lines. Known domains of the protein derived from Uniprot are
depicted as small blue boxes. In addition, we marked the
specific protein position with a red line where peptides
showed cleavage according to enzymatic digestion with Asp
C. This is because caspase cleavage followed by tryptic di-
gestion creates semitryptic peptides in shotgun proteomics
experiments that, if detected, can mark the exact site of
caspase cleavage. For these peptides, we distinguished
cleavages with high confidence (ratio [log2]  1.5) and inter-
mediate confidence (ratio [log2]  1.5); these values were
chosen based on the distribution of known caspase cleavage
products. For high-confidence cleavages, the explicit cleav-
age site is denoted in the output table, as well as the se-
quence window of 3 amino acids surrounding the cleavage
site. In addition, we calculated molecular weight distributions
that relate the position on the one-dimensional SDS gel to the
molecular weight of the proteins detected in the entire pro-
teome dataset of this experiment. This relationship is depicted
in supplemental Fig. S1B and is used to provide a molecular
weight scale on the right-hand y-axis of each plot. We further
manually inspected the automatically filtered candidates for
consistency across all six experiments (see below) and veri-
fied them for inclusion in the final substrate list.
Identification and Characterization of TRAIL-induced Pro-
teolytic Substrates—Because no global whole proteome
studies had been reported on the specific proteolytic sub-
strate spectrum of TRAIL-induced apoptosis, we treated
Jurkat T cells with different concentrations of TRAIL and
monitored their state over time via light microscopy (see “Ex-
perimental Procedures”). Based on the results, we chose a
TRAIL concentration of 100 ng/ml and stimulation for 5 h.
Microscopic, flow cytometric, and immunoblotting results
(Figs. 2A–2C) showed that this time point optimally covers
both upstream and downstream apoptotic events (initiating
caspases and substrates downstream of caspases, respec-
tively), which should allow us to cover a broad spectrum of
apoptotic cleavage events. In addition, the results of our H2O2
treatment—an unspecific cytotoxic agent—show that we
clearly separated apoptosis from uncontrolled necrotic cell
death (Figs. 2A and 2C).
FIG. 2. Apoptosis verification after
TRAIL induction. A, viability study after
induction of apoptosis or necrosis com-
pared with mock treatment. Cells were
treated with 0.1% H2O2 and 100 ng/ml
TRAIL or mock for several hours. The
permeability of the cells was checked
with a cell counter; cell numbers are
plotted. B, Western blot analysis of apo-
ptotic markers. Cleavage of the up-
stream substrate CASP8 and the down-
stream substrate PARP1 was detected
after TRAIL treatment within 24 h. Ar-
rows point to the treatment at 5 h, the
time point that was used for the SILAC
experiments. C, flow cytometry analysis
distinguishing between apoptosis and
necrosis. Experiments show a response
to propidium iodide and Annexin V-FITC
in mock, TRAIL, and H2O2 treatments.
TRAIL-treated cells revealed a clear re-
sponse to Annexin V after 5 h, but no
necrotic effects were detected.
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Next, we applied the above-mentioned conditions in a
SILAC experiment treating Jurkat T cells for 5 h with TRAIL
(100 ng/ml) and mock. We performed three biological double-
labeling experiments and three biological triple-labeling ex-
periments comparing TRAIL-treated and mock-treated states.
In the triple-labeling experiments, we used only the light and
heavy channels; the medium condition was additionally inhib-
itor treated, as mentioned below.
For substrate identification, we combined all six experi-
ments. When we identified a candidate as significant in one of
the experiments (FDR  5%), the software created a three-
dimensional cleavage plot for the other experiments (even if
they were not significant) to allow better comparison among
the different experiments. We derived significances for each
plot from the FDR columns of the output of our script and
counted how often each protein had been identified as sta-
tistically significant in the six experiments. In the final manual
validation, only candidates with an appropriate peptide distri-
bution pattern that were found to be significant at least three
times were designated as TRAIL-induced apoptosis sub-
strates and considered for further analyses (supplemental
Table S1).
This procedure identified a plethora of positive controls
known to be proteolytically cleaved during apoptosis, prom-
inent examples of which are presented in Fig 3A. CASP8
shows a clear uncleaved region with good sequence cover-
age. The N-terminal cleaved fragments in the range of 43 kDa
and 24 kDa corresponding to the most probable cleavage at
D374 and D216 are present (4). These two cleavage sites
correspond to the first and second cleavage of CASP8, for
which another cleavage at D384 is known. For the well-stud-
ied downstream substrate PARP1, we covered nearly the
complete sequence in the uncleaved region (113 kDa) with
highly negative ratios (indicating absence of the protein in the
treated state and therefore almost complete cleavage). In
addition, we also obtained high sequence coverage of the
fragments, and the mass of the fragments fit with their se-
quence region of the protein (89 kDa and 24 kDa). The region
of the cleavage site is clearly visible and is in agreement with
a known cleavage site on PARP1. This site, DEVD[214], is
located directly within the DNA-binding region. Through
cleavage of the N-terminal part of the protein, PARP1 ceases
to be recruited to the DNA and consequently loses its catalytic
activity in DNA damage repair. We also detected Caspase-3,
FIG. 3. Identification of TRAIL-induced cleaved substrates. A, positive markers of apoptotic cleavage. Three-dimensional cleavage plots
are depicted for the substrates CASP8 and PARP1. For both substrates, strong negative ratios were identified in the uncleaved region, whereas
cleaved fragments showed high positive ratios indicating strong cleavage. B, identification of known and novel substrates. Substrates detected
in our dataset were compared with a list of known substrates. Slightly more than half of the substrates were novel cleavage substrates induced
by TRAIL treatment. C, comparison of the whole proteome and the identified substrates. The intensity distribution of all proteins is depicted,
with the population of cleaved substrates highlighted in green. Cleavage substrates span the higher intensity region of the complete detected
proteome.
SILAC-based Approach to Globally Detect Protease Substrates
1442 Molecular & Cellular Proteomics 12.5
Caspase-6, and Caspase-2, and many other well-docu-
mented caspase substrates of both early and late cleavage
events such as BID, DFFA, PAK2, VIM, LMNB1/B2, and
ROCK1 (supplemental Table S1). BID mediates the crosstalk
between the extrinsic and intrinsic form of cell death via
accumulation of its 15-kDa fragment tBid at mitochondria,
initiating mitochondrial outer membrane permeabilization (36).
DFFA (ICAD) is an inhibitor of the DNase CAD, which is
inactivated by cleavage. Cleavage of this inhibitor then allows
free CAD to translocate to the DNA and degrade chromo-
somes into nucleosomal fragments, a characteristic feature of
apoptosis.
After statistical filtering and manual inspection, we obtained
693 cleaved substrates in response to TRAIL-induced apo-
ptosis (Fig. 3B; supplemental Fig. S2A). To generate a list of
known substrates for comparison, we accessed the caspase
substrate database CASBAH (37) and data from two large-
scale investigations (11, 23). This analysis showed that 304 of
our substrates were already known as verified or potential
caspase substrates, and 389 of our candidate proteins were
entirely novel. Together, these results demonstrate that our
screen covered a substantial part of the known substrates of
all caspase substrates while identifying a very large set of
novel TRAIL-induced cleavage products. This attests to the
sensitivity of our approach but also suggests that only a
fraction of all cleaved substrates have been described to date
(38, 39).
We next plotted the intensity distribution spanned by the
complete proteome experiment in comparison with the inten-
sity fraction covered by the statistically significant cleaved
substrates (Fig. 3C). Cleavage substrates were distributed
toward the higher abundant area of the complete proteome.
This is not surprising as verification, as a substrate requires
substantially more information than mere identification in the
proteome. Interestingly, although our data are biased toward
the more abundant part of the proteome, the substrates are
relatively flatly distributed across the accessible abundance
range. This shows that the tendency to be a caspase sub-
strate is not strongly correlated with protein abundance, at
least in the abundance range covered by this study.
Detected substrates span a broad molecular weight range
and encompass proteins ranging from about 20 kDa to up to
200 kDa. Nevertheless, very small proteins are underrepre-
sented within the substrate population, which might be the
result of limitations of the gel-based MS approach (supple-
mental Figs. S2B, S2C).
Proteolytic substrates are not necessarily the result of
caspase cleavage; they also can be cleaved by other pro-
teases, which could be either activated by or independent of
upstream caspase cleavage. To verify that the cleaved sub-
strates were truly caspase dependent, we incubated Jurkat T
cells with the pan-caspase inhibitor z-VAD-FMK before treat-
ment with TRAIL. We determined the best inhibitor conditions
by using different concentrations of z-VAD-FMK and the
known caspase substrate PARP1 (Fig. 4A). Based on these
results, we utilized a triple-SILAC approach treating SILAC-
labeled cells with mock (light SILAC condition), TRAIL (5 h;
FIG. 4. Identification of caspase dependence of the cleaved
substrates. A, inhibition of apoptosis by z-VAD-FMK. Different con-
centrations of the pan-caspase inhibitor z-VAD-FMK were tested, and
cleavage was detected via Western blot against the known caspase
substrate PARP1. The arrow points to the condition used for the
SILAC experiments. B, comparison of TRAIL-treated and inhibitor-
treated samples. TRAIL treatment generated a clear cleavage pattern,
as, for example, for PARP1, including characteristic ratios in the
uncleaved and cleaved regions (upper panel). Inhibitor-treated sam-
ples showed no characteristic ratio pattern (lower panel). In some
cases, slight background cleavage could be detected in both mock
and treated samples generating peptides in the fragment slices with
1:1 ratios. Red arrows highlight the localization of the known cleavage
site.
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heavy SILAC condition), or TRAIL (5 h) and z-VAD-FMK at 50
M (medium SILAC condition). We performed three biological
replicate experiments and analyzed the samples as described
under “Experimental Procedures.” TRAIL-treated samples
(heavy/light ratio) showed clear cleavage patterns (Fig. 4B,
upper panel), whereas inhibitor-treated samples showed no
peptide ratio difference relative to the mock-treated popula-
tion (Fig. 4B, lower panel) (medium/light ratio). Note that pep-
tides of caspase-dependent substrates such as PARP1 could
also be found in molecular weight regions of the cleavage
fragments; however, these have one-to-one SILAC ratios (0 in
log2) between inhibitor-treated and control conditions, show-
ing that they originate from background (TRAIL-independent)
cleavage. Because all significant cleavage events were abol-
ished by the inhibitor, we conclude that they all were caspase
dependent.
FIG. 5. Localization of cleavage sites. A, detection of explicit cleavage sites. As a representative example of explicit cleavage site detection,
the novel substrate LYAR is depicted, for which an explicit cleavage was detected at D281. The peptide cleaved C-terminally of Asp was
identified with high confidence and matched with a hypothetical cleavage site, whereas the uncleaved peptide was identified in the slice
containing the uncleaved protein with a negative ratio. B, evaluation of caspase specificity via sequence logo representation. We extracted the
sequence windows (Asp  3aa) of all explicit cleavage sites and generated a sequence logo for the substrates. The output data matched with
current knowledge and supported the preference for small amino acids at position P1	. C, representation of categories providing information
on cleaved regions. Besides explicit cleavage sites, cleaved regions could be narrowed down to small regions along the protein sequence. We
defined four different categories describing the information obtained about the cleavage position. D, multiple cleavages by caspases. In several
cases, multiple cleavage events could be located within one protein. Protein MCM6, for example, was cleaved at the same time either once
or twice along its protein sequence, generating five different cleavage fragments. The explicit cleavage site D274 is indicated by a red arrow;
the black arrow highlights the approximate second cleavage site.
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Identification of Proteolytic Cleavage Sites—In addition to
identifying cleavage substrates of caspases, our approach
might allow the identification of specific caspase cleavage
sites in a subset of cases. To test this, we searched for
peptides with either an N- or a C-terminal caspase cleavage
site and a tryptic site on the other terminus. We also required
that the peptide is located in the region indicated by our
statistical algorithm as the probable cleaved region (see “Ex-
perimental Procedures”). Using this approach, we were in-
deed able to identify 93 explicit cleavage events in 86 pro-
teins, including known ones that served as positive controls
and novel ones. These sites, including the sequence windows
of 3 amino acids, are listed in supplemental Table S3. Sev-
eral novel potential substrates such as the cell-growth-regu-
lating nucleolar protein LYAR also were found in this way (Fig.
5A). For this protein, we mapped the cleavage site to the
position D281 overlapping with the hypothetical cleavage mo-
tif x[ET]xD. A sequence logo analysis (Fig. 5B) supported
earlier findings on intrinsically induced apoptosis that charac-
terized cleavage motifs as diverse (6). Cleavage is common at
an aspartate C-terminal to a small amino acid such as serine,
glycine, or alanine, as reported previously (6, 11). We con-
cluded from this that TRAIL-induced cleavage patterns are
similar to those observed in intrinsic caspase-mediated
events.
In cases when the caspase-cleaved peptide was not con-
fidently identified, the cleavage event was often still mappable
to a particular region of the protein. In 159 proteins, the
cleavage was mapped to a region of about 100 amino acids
(Fig. 5C; supplemental Table S3). In 50 of these cases, the
cleavage area overlapped with only one x[ET]xD motif (implicit
sites). In 85 proteins, there was more than one motif in the
cleavage area (area). In the remaining cases, a different cleav-
age motif was presumably used by the responsible protease.
In several cases, we determined multiple cleavage events
within the same protein (Fig. 5D). We found, for instance, two
cleavage events in the DNA replication licensing factor
MCM6, one of which was already known and could be
mapped directly as an explicit site (D274). For the second
cleavage, two possible motifs matched within the C-terminal
region close to position 770. From the positions of the frag-
ments in the gel, we determined that either or both cleavages
can occur, indicating that there appears to be no preference
for one of them as an initiator site (Fig. 5D). As either cleavage
presumably inactivates the protein, such a cleavage pattern is
functionally sensible for substrate inactivation.
As these results show, our whole protein approach is not
necessarily limited to the identification of cleaved proteins
and in many cases might yield detailed information about the
cleavage site or region. Even the identification of cleavage
regions can already be of great importance for tracking the
effect of the cleavage by providing information about cleaved
domains or motifs, for instance.
Global Analysis of Detected Proteolytic Events—Bioinfor-
matic analysis of our substrate proteome revealed that it
covered a broad range of different pathways with known and
novel substrates showing similar trends (supplemental Table
S4). In particular, many substrates belong to RNA-dependent
pathways, endocytosis, spliceosomal, and cell-cycle-related
processes. We next extracted protein populations enriched or
depleted in our substrate population relative to the complete
detected proteome using Fisher’s exact test (Benjamini–
Hochberg FDR  0.02). Because the substrate population is
biased toward higher protein expression, as determined ear-
lier (Fig. 3C), we first created a background protein population
spanning the same intensity region as the cleaved substrates
(Fig. 6A) to serve as a reference population. Interestingly, the
substrates showed an asymmetric distribution between de-
pleted and enriched categories (supplemental Table S5).
TRAIL-induced apoptosis appears to target a broad range of
functions without strong preferences, whereas a small num-
ber of pathways and compartments were clearly selected
against. The latter encompassed the endoplasmic reticulum,
mitochondria, and inner membrane proteins in general, as
discussed below.
RNA-regulated processes including RNA helicase activity
and RNA splicing in particular, but also pathways such as
endocytosis (CLTA, AP2A1, AP2A2, DNM2) (40), were signif-
icantly enriched in cleaved substrates. Nuclear proteins were
slightly but statistically significantly enriched, as were proteins
in complexes (derived from the CORUM database (41)) (Fig.
6B). In contrast, proteins intrinsic to membrane were signifi-
cantly underrepresented, and proteins in mitochondria and
endoplasmic reticulum were underrepresented by more than
200% within the cleaved substrate fraction (Fig. 6B). Proteins
in endoplasmic reticulum and mitochondria might not be ac-
cessible to caspases, or they might not contain as many
cleavage sites (cleavage motifs) because they have to fulfill
important tasks in controlled cell death. In any case, this is an
interesting observation given that mitochondria dynamics and
fission are known apoptotic effects (42). Regardless of the
mechanism, our data indicate that the mitochondria are pro-
tected from caspase cleavage, which appears reasonable
given the central function of mitochondria in intrinsically in-
duced—but also extrinsically caused—apoptosis. In contrast,
nuclear pore proteins are preferentially cleaved by caspases,
and nuclear proteins are enriched as substrates, which is in
agreement with the fact that nuclear breakdown is a hallmark
of apoptosis.
The preceding analysis was focused on the identity of the
substrate proteins only. In a next step, by evaluating the
SILAC ratios of the apoptotic substrates at the gel positions of
the full-length proteins (uncleaved ratios), we noticed that
they displayed in all experiments a bimodal distribution (Fig.
6C). Classical upstream (e.g. caspases) and downstream sub-
strates (e.g. PARP1, LMNB2, ROCK1) were observed with
strong negative ratios, indicating that a large percentage of
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these substrates had been cleaved at this time point (5 h). In
contrast, proteins in the right-hand peak had ratios around
zero, indicating that most of these proteins remained un-
cleaved, even though fragments with clear positive ratios
marked them as apoptotic substrates. Splitting the population
into novel and known substrates showed a clear tendency of
novel substrates toward the right-hand distribution (low per-
centage of substrate cleavage; supplemental Fig. S3A). This
might reflect the sensitivity of our approach, as proteins
cleaved with lower stoichiometry are more difficult to detect.
Bioinformatic analysis of the enrichment of protein classes
within the two different peaks with a Fisher’s exact test
(Benjamini–Hochberg FDR  0.02) revealed that proteins in
complexes were highly enriched in the right-hand peak (Fig.
6D; supplemental Fig. S3B). Thus complex members often
appear to be cleaved with less efficiency than proteins not
involved in complexes.
Caspase Cleavage of the Condensin Complex—To perform
a physical and functional interaction analysis of our substrate
population, we used the STRING database (STRING 9.0; high-
est confidence (score 0.90)) and visualized and analyzed re-
sults in Cytoscape (version 2.8.2). We grouped the substrates
into known and novel proteins (green and red, respectively, in
supplemental Fig. S4). The center of the interaction network
was formed by Caspase-3 surrounded by many known sub-
strates such as CASP6, BID, LMNB1, PAK2, and ROCK1.
Novel substrates created additional links between known
cleavage substrates but also spanned further networks at the
periphery of the graph. Protein clusters highlighted interac-
tions of ribosomal and nuclear pore proteins, as well as of
proteins involved in protein biosynthesis, DNA replication,
transcription, vesicle transport, and endocytosis, defined by
both known and novel substrates. We also noticed entire
macromolecular complexes, among which proteasomal pro-
teins and the condensin I complex were prominent. The latter
is of special interest because it plays a crucial role in the
formation of structurally stable mitotic chromosomes and
their segregation, as well as in gene regulation and DNA repair
FIG. 6. Global analysis of cleaved substrates. A, calculation of a background population for enrichment testing. To perform unbiased
enrichment testing of cleavage substrates versus the whole proteome, a background population was extracted from the whole proteome data
spanning intensity ranges equal to those of the substrate population. All three categories are depicted. B, enrichment analysis of substrates.
Proteins in complexes are slightly enriched within the substrate population. Proteins assigned to mitochondrion are significantly de-enriched
within the substrate population. Bg, background. C, distribution of uncleaved ratios of all substrates. Median ratios of the uncleaved protein
regions follow a clear bimodal distribution in all experiments. D, representation of uncleaved protein ratios with regard to proteins in complexes.
Substrates annotated in CORUM showed clear tendencies toward the right-hand peak; substrates not assigned to complexes tended toward
stronger negative ratios.
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(43, 44). The pentameric condensin I complex is highly con-
served and ubiquitously found among eukaryotes. It consists
of two structural maintenance of chromosome ATPase sub-
units and three auxiliary subunits. Only one component of the
complex, the kleisin subunit NCAPH, has been reported to be
cleaved upon apoptosis induction to date. This cleavage was
thought to be responsible for the loss of the condensin I
complex in apoptosis, contributing to a loss of chromosome
structure and chromosome susceptibility to DNA fragmenta-
tion induced by a caspase-activated DNase (45).
Interestingly, we identified not only NCAPH but also all
other components of the complex as cleaved substrates after
TRAIL induction (Fig. 7A; supplemental Fig. S5). To better
understand the process of condensin I complex cleavage, we
extracted the three-dimensional cleavage plots of all of its
members. The known substrate NCAPH was strongly cleaved
in the middle of the protein, as already described in the
literature. However, our detected cleavage site (D380), which
matches with a potential cleavage motif, does not overlap
with the known cleavage site at D366. The novel substrates of
this complex SMC2, SMC4, NCAPD2, and NCAPG showed
cleavage at the N- or C-termini, resulting in a slight shift of the
uncleaved protein. These substrates were cleaved with less
efficiency than the known substrate NCAPH. Both structural
maintenance of chromosome ATPase subunits (SMC2 and
SMC4) have nucleotide-binding domains at their N- and C-
terminus, termed Walker A and B motifs. Within each protein,
these domains interact with each other and form so-called
head domains. We detected cleavages in both proteins at
their N- and C-termini. Interestingly, for SMC2 we could even
map an explicit cleavage site at the C-terminal part of the
protein located exactly within the Walker B motif at D1116.
This is remarkable because ATP-binding pockets should be
difficult to access. For NCAPD2 and NCAPG, we also de-
tected cleavage at the N- and C-terminus, respectively. These
cleavage sites appear to overlap with important intra- and
intermolecular interaction sites of the other proteins of the
complex. Interestingly, NCAPD3 from the related condensin II
complex was cleaved as well. However, in this case we lo-
cated this cleavage site at position D529 in the middle part of
the sequence, rather than the termini. This might indicate
different modes of association of NCAPD2 and NCAPD3 with
their corresponding kleisin subunits.
A recent paper investigated the function of yeast condensin
by introducing several TEV cleavage sites into Brn1 (NCAPH
homologue) (46). Interestingly, cleavage of NCAPH leads to
opening of the condensin ring, but without releasing subunits
of the complex. Intriguingly, after cleavage of NCAPH, the
complex is still associated with the chromosome if the two
NCAPH fragments are held together by interactions with
NCAPD2, at least in vitro. After additional cleavage of
NCAPD2, condensin is released from the chromosomes. Also,
in the case of SMC2 coiled coil artificial cleavage of both
strands was necessary for inactivation. In light of these find-
ings and our data, we suggest that simple cleavage of NCAPH
by caspases might not be sufficient to release condensin from
the chromosome. Additional proteolytic cleavage events in
other subunits—preferentially at the interaction sites—might
be necessary in order to fully inactivate the complex and
disengage its components. Sites in condensin I complex sub-
units other than NCAPH were observed with lower SILAC fold
changes, suggesting that the specific location of cleavage is
less important than the fact that a second cleavage occurs.
Although these mechanisms are speculative, the cleavage
sites identified here are mechanistically plausible and may
serve as starting points for further functional dissection of the
cleavage of the complex.
Caspase Cleavages of the Proteasome—Recently, several
groups have suggested that protein degradation by caspases
and by the proteasome are interlinked by the reciprocal cleav-
age of some of its components, and several proteasomal
subunits have been identified as apoptosis substrates (6).
Here we identified cleavage events in the 20S core particle
and in the 19S regulatory particles, covering both base and lid
proteins (47, 48) (supplemental Fig. S6). As with the condensin
complex, stoichiometries of substrate cleavages were rela-
tively low. From the regulatory particles, we found the previ-
ously known substrate subunits Rpn2, Rpn3, Rpn10, Rpt1,
Rpt5, Rpt6, and Rpt4, as well as the novel substrates Rpn5
and Rpt2 (6). From the core particle, we identified PSMA5 and
also observed cleavage of the 11S regulatory cap, PA28.
These findings support the hypothesis of a negative feedback
loop in which caspases and the proteasome are interlinked in
the process of apoptosis (49). In healthy cells, caspases as
the effectors of apoptosis are tightly regulated by the protea-
some, and their protein levels are reduced via proteasomal
control. Upon caspase activation by apoptosis, proteins
mainly within the regulatory part of the proteasome are
cleaved in a caspase-dependent manner, and proteasomal
degradation is inhibited. Our findings support this general
picture and supply a number of specific substrates and sites
in the proteasome.
An earlier study identified caspase cleavage of three pro-
teins of the 19S regulator particle complex of the 26S protea-
some. PSMC3 (Rpt5) and PSMD4 (Rpn10) most probably
recognize the polyubiquitinated proteins, whereas PSMD1
(Rpn2) most likely holds together the lid and the base of the
19S regulator particle (49). Their cleavage might inactivate this
process and partially detach the 19S regulator particle from
the 20S core particle. Our data substantiate the cleavage sites
of PSMC3 and PSMD1. For PSMD4, two possible cleavage
sites were posited in an earlier study. Our results clearly
identify cleavage at one of them, D258.
The SILAC ratios observed in our data are relatively low,
suggesting sub-stoichiometric cleavage at different sites for
each member protein of a complex. In order to compensate
for this lower cleavage efficiency, caspases appear to cleave
several members of the same protein complex, such as the
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FIG. 7. Investigation of specific cleavage substrates in a biological context. A, cleavage of the condensin I complex members. All
components of the condensin I complex were identified as cleavage substrates. For the novel substrate SMC2, an explicit cleavage site was
identified within the C-terminal Walker B motif (upper panel) at D1116. The known cleavage substrate NCAPH was strongly cleaved in the
middle of the protein sequence, but the detected explicit cleavage site at D380 did not exactly match the literature (lower panel). B,
identification of the autophagic protein ATG3 as a caspase substrate. We mapped an explicit cleavage site to D104 within the ATG3 sequence.
Cleavage fragments indicate an additional cleavage within the C-terminal fragment.
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proteasome, perhaps with a more robust inactivation effect as
the cleavage of one specific protein.
Caspase Cleavages of the Autophagy Apparatus—The link
between apoptosis and autophagy is also of special interest
(see, for instance, Ref. 50). Autophagy is cytoprotective,
whereas apoptosis inhibits autophagy when activated, coun-
teracting its effects. Important points of crosstalk include the
interaction of the autophagy protein Beclin-1 and the anti-
apoptotic factor Bcl-2, as well as direct interactions of
caspases and autophagic components. A recent study de-
scribed the cleavage of the early autophagy marker ATG3 by
CASP8 (51) as an important link between both pathways. The
authors focused on the in silico derived site D169 and in an
experimental follow-up defined it as the cleavage site of
CASP8 leading to the inactivation of the autophagic process
after TNF or TRAIL induction. Here, we also detected ATG3
cleavage after TRAIL induction in our Jurkat T cell system, and
we identified a cleavage region including two possible sites,
D169 being one of them (Fig. 7B, supplemental Table S1).
Furthermore, we mapped an explicit cleavage site of ATG3 at
D104. That site had also been found in another study (23),
supporting our results. Based on the peptide information from
the cleaved fragments, the cleavage at D104 appears to be
more prominent than that at D169. Because peptides from
the counterpart of the D169 cleavage are absent in the gel, we
speculate that this cleavage is secondary. In any case, the
detection of two cleavage events via our method illustrates its
depth and its unbiased nature.
CONCLUSIONS AND OUTLOOK
Here we have described a quantitative SILAC-based ap-
proach for the identification of proteolytically cleaved sub-
strates and used it to investigate the events of apoptosis
induced by the extrinsic stimulus TRAIL. Our approach un-
covered nearly 700 cleavage substrates, a dataset that can
serve as a resource for studying TRAIL-induced cleavage
events for the community of cell death researchers. It also
might be clinically relevant, because TRAIL is of great impor-
tance for cancer therapy research aiming to preferentially
inducing apoptosis in tumor cells but not in normal cells (52,
53). In addition, our approach can be applied to any system in
which proteolytic cleavage occurs and could therefore also be
of interest in fields such as embryogenesis or neurodegen-
erative disease research.
After this study was finished, Cravatt and co-workers incor-
porated SILAC into their PROTOMAP approach (23) and ele-
gantly used it to discover the requirement of priming phos-
phorylation events for apoptotic cleavage events (25). They
investigated staurosporine-induced apoptosis, rather than ex-
trinsic ligand-induced apoptosis. They detect about 700
cleaved substrates, which is reduced to about 500 substrates
when an indication of cleavage products in lower molecular
weight gel regions is required, as was the case in our study.
About 300 substrates are common to both approaches, indi-
cating that many of the same substrates are cleaved following
intrinsic and extrinsic stimulation of apoptosis. Nevertheless,
it is clear that neither approach reached completion and that
there are a large number of apoptotic substrates still to be
discovered. Already from the data acquired here, several fea-
tures of the apoptotic substrate proteome have become ap-
parent. For instance, we found that mitochondria are clearly
underrepresented as cleavage substrates and that stable
complexes appear to be disabled by several apoptotic cleav-
age events in different complex members, each with less than
full stoichiometry. Our data also support the notion that apo-
ptotic cleavage events are not randomly distributed in the
cellular proteome and instead target specific proteins and
pathways (39). In this regard, it is interesting to note that many
of the novel substrates discovered here link to already known
targets or networks. In conclusion, we note that MS-based
proteomics is still improving in terms of the speed and depth
of analysis and that it should soon be possible to investigate
and compare different apoptotic stimuli and conditions, as
well as inhibitors, providing valuable input for studying the
mechanisms of apoptosis.
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